Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Annals of the New York Academy of Sciences
|
January 1, 1991
Transdermal delivery of testosterone with Testoderm to provide a normal circadian pattern of testosterone
V A Place, K C Nichols
The Journal of Reproductive Medicine
|
August 1, 1974
Progress in the development of the Progestasert TM 65 progesterone therapeutic system for contraception
V A Place, B B Pharriss
JAMA
|
January 19, 1970
Extemporaneous formulation of corticosteroids for topical usage
K H Burdick, B Poulsen, V A Place
Archives of Dermatology
|
May 1, 1970
Precise evaluation of topically applied corticosteroid potency. Modification of the Stoughton-McKenzie assay
V A Place, J G Velazquez, K H Burdick
The Journal of Clinical Endocrinology and Metabolism
|
February 1, 1987
Transdermal delivery of testosterone
J C Findlay, V A Place, P J Snyder
Acta Endocrinologica
|
May 1, 1988
Substitution therapy of hypogonadal men with transdermal testosterone over one year
M Bals-Pratsch, K Langer, V A Place, et al.
The Journal of Reproductive Medicine
|
August 1, 1976
Steroid delivery systems for contraception
B B Pharriss, V A Place, L Sendelbeck, et al.
American Journal of Ophthalmology
|
October 1, 1975
Comparative pharmacologic effects of pilocarpine administered to normal subjects by eyedrops or by ocular therapeutic systems
V A Place, M Fisher, S Herbst, et al.
Acta Dermato-Venereologica. Supplementum
|
May 1, 1971
The croton oil inflammation suppression assay as a measure of topical corticosteroid potency
E Ortega, C Rodriguez, K H Burdick, et al.
American Journal of Obstetrics and Gynecology
|
August 15, 1985
A double-blind comparative study of Estraderm and Premarin in the amelioration of postmenopausal symptoms
V A Place, M Powers, P E Darley, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Annals of the New York Academy of Sciences
|
January 1, 1991
Transdermal delivery of testosterone with Testoderm to provide a normal circadian pattern of testosterone
V A Place, K C Nichols
The Journal of Reproductive Medicine
|
August 1, 1974
Progress in the development of the Progestasert TM 65 progesterone therapeutic system for contraception
V A Place, B B Pharriss
JAMA
|
January 19, 1970
Extemporaneous formulation of corticosteroids for topical usage
K H Burdick, B Poulsen, V A Place
Archives of Dermatology
|
May 1, 1970
Precise evaluation of topically applied corticosteroid potency. Modification of the Stoughton-McKenzie assay
V A Place, J G Velazquez, K H Burdick
The Journal of Clinical Endocrinology and Metabolism
|
February 1, 1987
Transdermal delivery of testosterone
J C Findlay, V A Place, P J Snyder
Acta Endocrinologica
|
May 1, 1988
Substitution therapy of hypogonadal men with transdermal testosterone over one year
M Bals-Pratsch, K Langer, V A Place, et al.
The Journal of Reproductive Medicine
|
August 1, 1976
Steroid delivery systems for contraception
B B Pharriss, V A Place, L Sendelbeck, et al.
American Journal of Ophthalmology
|
October 1, 1975
Comparative pharmacologic effects of pilocarpine administered to normal subjects by eyedrops or by ocular therapeutic systems
V A Place, M Fisher, S Herbst, et al.
Acta Dermato-Venereologica. Supplementum
|
May 1, 1971
The croton oil inflammation suppression assay as a measure of topical corticosteroid potency
E Ortega, C Rodriguez, K H Burdick, et al.
American Journal of Obstetrics and Gynecology
|
August 15, 1985
A double-blind comparative study of Estraderm and Premarin in the amelioration of postmenopausal symptoms
V A Place, M Powers, P E Darley, et al.
Page
of 2